Drugs group | HSP90* | PI3K-AKT¥ | mTOR† | Angiog. ‡ | EGFR Retal₤ | MT/Cyts** | RasRaf*** | Cell cycle ∘ | HDAC∘∘ | Average |
---|---|---|---|---|---|---|---|---|---|---|
Targets | I∘∘∘ | II†† | III‡‡ | IV₤₤ | Va | VIb | VIIc | VIIId | IXe | |
Lf | ||||||||||
MCF-7 | 6.43 | 5.92 | 6.32 | 4.47 | 4.65 | 7.27 | 4.99 | 5.57 | 5.54 | 5.69 |
T-47D | NA | 6.21 | 6.08 | 4.56 | 4.62 | 6.33 | 4.63 | 5.49 | 5.57 | 5.44 |
ZR-75-1 | 6.74 | 5.66 | 4.18 | 4.41 | 4.57 | 6.91 | 4.95 | 5.13 | 5.22 | 5.31 |
BT-474 | 7.77 | 6.42 | 7.84 | 4.58 | 5.73 | 6.93 | 4.55 | 5.14 | 5.82 | 6.09 |
Correl.g | −0.462 | −0.746 | −0.953 | −0.699 | −0.704 | −0.327 | 0.420 | −0.222 | −0.918 | −0.923 |
TNh | ||||||||||
BT-20 | NA | 5.38 | 6.99 | 4.47 | 4.99 | 7.00 | 4.81 | 5.40 | 5.09 | 5.52 |
MDA-MB-231 | 6.82 | 5.06 | 5.45 | 4.42 | 4.65 | 7.70 | 5.22 | 5.18 | 4.68 | 5.47 |
MDA-MB-468 | 6.59 | 5.70 | 5.40 | 4.38 | 4.90 | 7.78 | 4.78 | 6.31 | 5.19 | 5.67 |
Correl. | 1.000 | −0.504 | 0.877 | 0.998 | 0.245 | −0.905 | 0.064 | −0.764 | −0.189 | −0.725 |
Tot. correl.i | −0.391 | −0.605 | −0.528 | −0.411 | −0.546 | −0.205 | 0.351 | −0.298 | −0.588 | −0.859 |